Paper6985745
Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite.
Yoshida N and 4 others. Science, 1980. Cited by 467 papers, by iCite.
Cite this record
ConductScience Library. Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite. Papers, record 6985745. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6985745
- Cell line
- 3D11 [Mouse hybridoma against P.berghei csp]1 paper
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies | Major topic |
| Malaria | Major topic |
| Plasmodium berghei | Major topic |
| Animals | |
| Antigens, Surface | |
| Clone Cells | |
| Hybrid Cells | |
| Membrane Proteins | |
| Mice | |
| Molecular Weight | |
| Myeloma Proteins | |
| Neoplasms, Experimental | |
| Plasmacytoma | |
| Spleen |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01082341 | Immunization of Human Volunteers With P. Vivax Irradiated Sporozoites | Background |
Source ClinicalTrials.gov
Cited by192
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 467 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42856535 | Protective near-germline antibodies to malaria elicited by RTS,S/AS01E vaccination in African infants. | bioRxiv | 2026 | https://conductscience.org/library/papers/42856535 | PubMed |
| 42709869 | TKL3 regulates blood-stage fitness, male gamete fertility, and transmission-stage development in Plasmodium berghei. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/42709869 | PubMed |
| 42478140 | A Novel Plasmodium berghei Protein, LSMP, Regulates Malaria Liver Stage Maturation. | Mol Microbiol | 2026 | https://conductscience.org/library/papers/42478140 | PubMed |
| 42045549 | Sporozoite egress from Plasmodium oocysts requires a trimeric NF-Y-like complex. | Commun Biol | 2026 | https://conductscience.org/library/papers/42045549 | PubMed |
| 41395979 | Plasmodium DNA ligase I is essential for parasite blood- and liver-stage development. | mSphere | 2026 | https://conductscience.org/library/papers/41395979 | PubMed |
| 40983687 | The Plasmodium CSP repeats have elastic properties with a critical role in sporozoite motility. | EMBO J | 2025 | https://conductscience.org/library/papers/40983687 | PubMed |
| 40379677 | A Plasmodium LARC GAP provides preerythrocytic, stage and species transcending protection in mice. | NPJ Vaccines | 2025 | https://conductscience.org/library/papers/40379677 | PubMed |
| 39951341 | Late killing of Plasmodium berghei sporozoites in the liver by an anti-circumsporozoite protein antibody. | Elife | 2025 | https://conductscience.org/library/papers/39951341 | PubMed |
| 39745947 | Protective antibodies target cryptic epitope unmasked by cleavage of malaria sporozoite protein. | Science | 2025 | https://conductscience.org/library/papers/39745947 | PubMed |
| 39714137 | Autophagy protein Atg7 is essential for maintaining malaria parasite cellular homeostasis and organelle biogenesis. | mBio | 2025 | https://conductscience.org/library/papers/39714137 | PubMed |
| 39424860 | A Plasmodium late liver stage arresting GAP provides superior protection in mice. | NPJ Vaccines | 2024 | https://conductscience.org/library/papers/39424860 | PubMed |
| 38656211 | Vaccines and monoclonal antibodies: new tools for malaria control. | Clin Microbiol Rev | 2024 | https://conductscience.org/library/papers/38656211 | PubMed |
| 38354186 | The Anopheles leucine-rich repeat protein APL1C is a pathogen binding factor recognizing Plasmodium ookinetes and sporozoites. | PLoS Pathog | 2024 | https://conductscience.org/library/papers/38354186 | PubMed |
| 38318178 | CD8+ Trms against malaria liver-stage: prospects and challenges. | Front Immunol | 2024 | https://conductscience.org/library/papers/38318178 | PubMed |
| 38277340 | Longitudinal analysis of antibody responses to Plasmodium vivax sporozoite antigens following natural infection. | PLoS Negl Trop Dis | 2024 | https://conductscience.org/library/papers/38277340 | PubMed |
| 38007690 | Molecular determinants of cross-reactivity and potency by VH3-33 antibodies against the Plasmodium falciparum circumsporozoite protein. | Cell Rep | 2023 | https://conductscience.org/library/papers/38007690 | PubMed |
| 37703302 | Preliminary characterization of Plasmodium vivax sporozoite antigens as pre-erythrocytic vaccine candidates. | PLoS Negl Trop Dis | 2023 | https://conductscience.org/library/papers/37703302 | PubMed |
| 37389992 | Cytotoxicity of human antibodies targeting the circumsporozoite protein is amplified by 3D substrate and correlates with protection. | Cell Rep | 2023 | https://conductscience.org/library/papers/37389992 | PubMed |
| 37306042 | Conformational change of Plasmodium TRAP is essential for sporozoite migration and transmission. | EMBO Rep | 2023 | https://conductscience.org/library/papers/37306042 | PubMed |
| 37191558 | Plasmodium falciparum Gametes and Sporozoites Hijack Plasmin and Factor H To Evade Host Complement Killing. | Microbiol Spectr | 2023 | https://conductscience.org/library/papers/37191558 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6985745
GET https://conductscience.org/api/papers/v1/6985745/cited_by?page=2